 
          手机扫码访问本站
 
 
        微信咨询
		
	
| Background: | Regulated degradation of misfolded, damaged or short-lived proteins in eukaryotes occurs via the ubiquitin (Ub)-proteasome system (UPS). An integral part of the UPS system is the ubiquitination of target proteins and covalent linkage of Ub-containing proteins to form polymeric chains, marking them as targets for 26S proteasome-mediated degradation. Ubiquitination of proteins is mediated by a cascade of enzymes which includes E1 (ubiquitin activating), E2 (ubiquitin conjugating), and E3 (ubiquitin ligases) enzymes. This gene encodes a member of the E2 enzyme family. Substrates of this enzyme include the tumor suppressor protein p53 and peroxisomal biogenesis factor 5 (PEX5). Alternative splicing results in multiple transcript variants of this gene. | 
| Applications: | WB | 
| Name of antibody: | UBE2D2 | 
| Immunogen: | Synthesized peptide derived from C-terminal of human UBE2D2. | 
| Full name: | ubiquitin-conjugating enzyme E2D 2 | 
| Synonyms: | UBC4; PUBC1; UBCH4; UBC4/5; UBCH5B; E2(17)KB2 | 
| SwissProt: | P62837 | 
| WB Predicted band size: | 17 kDa | 
| WB Positive control: | Hela cells, A549 cells and K562 cells lysates | 
| WB Recommended dilution: | 500-3000 | 
	
	